Table 1.
Controls (n = 34) | TLE patients (n = 34) | |
---|---|---|
Biomarkers | ||
Heat shock protein 70 (μg/ml) | 130.84 ± 61.1 | 194.5 ± 116.1** |
Non-specific enolase (ng/ml) | 9.43 ± 1.9 | 9.51 ± 1.9 |
S100ß protein (pg/ml) | 70.52 ± 28.0 | 99.83 ± 45.7 ** |
Plasma nuclear DNA (ng/ml) | 28.62 ± 2.5 | 29.19 ± 2.7 |
Plasma mitochondrial DNA (ng/ml) | 21.33 ± 1.1 | 21.15 ± 1.0 |
Verbal Memory CVLT-MS (9) | ||
T1 | 6.18 ± 1.1 | 5.18 ± 1.5** |
T2 | 7.74 ± 1.1 | 7.36 ± 1.4 |
T3 | 8.24 ± 0.9 | 8.06 ± 1.2 |
T4 | 8.59 ± 0.7 | 8.15 ± 1.0 |
30 sec free recall | 8.65 ± 0.7 | 7.67 ± 2.0** |
10-min free recall | 8.38 ± 1.2 | 7.18 ± 2.3** |
10-min recognition | 8.53 ± 0.9 | 7.55 ± 1.8 |
Visual Memory | ||
Modified Rey-Osterrieth recall (17) | 15 ± 2.5 | 11.64 ± 4.5** |
Visuospatial Functions | ||
Modified Rey-Osterrieth copy (17) | 17 ± 0 | 16.79 ± 0.7 |
Cube copy (2) | 1.82 ± 0.5 | 1.05 ± 0.9 |
Pentagon copy (1) | 1 ± 0 | 0.82 ± 0.4 |
Visual object and space perception (10) | 8.29 ± 2.0 | 8.64 ± 1.8 |
Speech and Language Ability | ||
Semantic Fluency (1 minute) | ||
Animal | 21.59 ± 3.9 | 15.3 ± 5.4** |
Fruit | 15.75 ± 2.8 | 11.54 ± 3.4** |
Transportation | 13.83 ± 3.8 | 9.26 ± 2.1** |
Town | 24.28 ± 6.2 | 16.82 ± 6.2** |
Boston naming test (16) | 15.58 ± 0.8 | 14.36 ± 2.2** |
Comprehension (4) | 3.88 ± 0.3 | 3.51 ± 0.9 |
Abstract thinking (3) | 2.58 ± 0.7 | 1.97 ± 1.2 |
Problem solving (3) | 2.60 ± 0.7 | 2.00 ± 1.1 |
Executive function | ||
Digit backward | 5.0 ± 1.6 | 4.74 ±1.5 |
Stroop interference correct (1 minute) | 54.1 ± 10.9 | 40.33 ± 14.6** |
Design fluency | 10.78 ± 3.0 | 8.56 ± 5.6* |
Trail Making test time (< 120 seconds) | 23.6 ± 11.6 | 47.8 ± 35.3** |
Correct line in Trail Making (14) | 13.13 ± 2.7 | 11.92 ± 3.5 |
Calculation (5) | 4.75 ± 0.7 | 4.51 ± 0.8 |
Digit forward | 8.40 ± 0.8 | 7.44 ± 1.4** |
Neuropsychiatric inventory score | 1.91 ± 6.6 | 2.84 ± 5.5 |
Values expressed as mean ± standard deviation.
Number in parenthesis following task name = maximal scores
**p < 0.01. *p < 0.05 between TLE patients and controls
TLE temporal lobe epilepsy; CVLT-MS California Verbal Learning Test-Mental Status